This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?
This CME Activity has expired and is no longer available for credit.

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Clinical Convergence<sup>SM</sup>: Patient and Provider Perspectives in BED: Follow-up Visits

Clinical ConvergenceSM: Patient and Provider Perspectives in BED: Follow-up Visits

Format

Patient Case Study

Time to Complete

1 hour

Released

March 15, 2016

Expires

March 15, 2017
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Program Description

This unique Clinical ConvergenceSM platform integrates healthcare provider and patient perspectives with clinical content that focuses on the diagnosis and management of binge eating disorder (BED) through a series of office visits and video panel discussions that includes two patients. The program focuses on how management decisions impact patient health and outcomes. In this activity, we meet the patients for follow-up visits. You will have had the opportunity to meet these patients for the first time in the previous activity.

Intended Audience

Psychiatrists, primary care physicians, gynecologists, and nurse practitioners and physician assistants in psychiatry, primary care, and gynecology

Educational Objectives

After completing this activity, the participant will demonstrate the ability to:

  • Describe diagnostic criteria for binge eating disorder (BED) as well as common conditions with which BED comorbidly occurs
  • Implement screening for BED into daily practice among at-risk patients
  • Integrate evidence-based treatment strategies for BED, including pharmacologic and non-pharmacologic interventions

Accredited Provider

Jointly provided by Albert Einstein College of Medicine and RMEI, LLC

Commercial Supporter

This activity is supported by an independent medical educational grant from Shire.

Conflict Of Interest Disclosure Policy

The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relevant relationship(s) with a pharmaceutical, product, or device company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.

Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. Albert Einstein College of Medicine, CCME staff, has no relevant conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Faculty

Anna I. Guerdjikova, PhD, LISW, CCRC
Director of Administrative Services
Harold C. Schott Foundation Eating Disorders Program
Lindner Center of HOPE
Mason, OH
Research Assistant Professor
Department of Psychiatry
University of Cincinnati
Cincinnati, OH

Dr. Guerdjikova has affiliations with VIVUS, Inc. (Research).

Charles Vega, MD
Clinical Professor
Department of Family Medicine
University of California
Irvine, CA

Dr. Vega has affiliations with Shire (Speakers’ Bureau).

Accredited Provider Disclosure

Albert Einstein College of Medicine
The following Einstein peer reviewer reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Bruce J. Schwartz, MD, has no affiliations with commercial interests to disclose.

Publishing Staff Disclosures

RMEI, LLC.
Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
Amy Reeve has no affiliations with commercial interests to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and RMEI, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Albert Einstein College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 75% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate.

If you have any questions relating to the accreditation of this activity, please call Einstein CME at 718-920-6674.
Add to Queue